COVID-19 as a Risk Factor For Autoimmune Skin Disease
JAMA Dermatology
Clinical Summary
View sourceWhat was studied
The article addresses whether COVID-19 may act as a risk factor for autoimmune skin disease.
Related Questions
Explore related topics and deepen your understanding
What is the incidence of new-onset autoimmune skin disease after COVID-19 infection?What evidence links recent COVID-19 infection to new-onset autoimmune skin diseases?What new-onset autoimmune skin diseases have been reported after SARS-CoV-2 infection, and how strong is the association?What evidence links prior COVID-19 infection to new-onset autoimmune skin diseases?Do COVID-19 vaccines trigger or worsen autoimmune dermatologic conditions?Which autoimmune dermatologic conditions have been linked to prior SARS-CoV-2 infection, and over what timeframes?Best available cohort or registry data on post-COVID risk of psoriasis, vitiligo, and alopecia areataWhich autoimmune dermatologic conditions have been reported after SARS-CoV-2 infection or vaccination?How should clinicians monitor patients post–COVID-19 for signs of autoimmune skin disease?How should clinicians evaluate and follow patients with possible autoimmune skin disease after COVID-19?How do COVID-19 infection and vaccination differentially affect autoimmune dermatologic disease risk?How should clinicians monitor and counsel patients about cutaneous autoimmunity following COVID-19?